About PharmaScience
PharmaScience is a Healthcare company based in Montreal (Canada) founded in 1983. Generic, branded, and over-the-counter pharmaceuticals are manufactured for global markets. PharmaScience has completed 1 acquisition, including Aegera Therapeutics. Its website pharmascience.com draws about 14 thousand monthly visits. Its focus areas include Traditional Pharmaceuticals, Generics and Diversified. Its legal entity is Pharmascience inc.
Company details
PharmaScience was established in 1983 in Montreal, Canada, within the pharmaceutical sector. Generic, branded, and over-the-counter medications are produced across nearly 300 molecules in facilities compliant with regulatory standards. Domestic and international markets are served, while support resources and patient care programs are provided to healthcare professionals. A dedicated division handles specialty medications, and substantial resources are allocated to research and development efforts.
- Headquarters Montreal, Canada
- SectorsHealthcare
- Website category Health · Biotechnology and Pharmaceuticals
- Website pharmascience.com
- Social LinkedIn Facebook Instagram YouTube
- Legal Name Pharmascience Inc
- Latest Funding Round$1.5M (USD), Debt – Conventional
Oct 2006
- InvestorsDynex Capital
& 1 more
- Investments & Acquisitions
Apps and channels of PharmaScience
its YouTube channel Pharmascience has 5.76K subscribers and 30 videos.
Videos from PharmaScience
The most watched videos on PharmaScience's YouTube channel, Pharmascience (5.76K subscribers). Click a video to play it here.
More on Pharmascience.
Funding Insights of PharmaScience
- Total Rounds 6
- Last Round Debt – Conventional — $1.5M
- First Round $1.5M
(Dec 2005)
- Investors Count 2
All 6 funding rounds of PharmaScience with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Oct 2006 | $1.5M | Debt – Conventional | – | – | |
| May 2006 | $3.89M | Post-IPO | – | – | – |
| Mar 2006 | $500,000 | Post-IPO | – | – | – |
| Jan 2006 | $500,000 | Post-IPO | – | – | |
| Jan 2006 | $500,000 | Post-IPO | – | – | – |
| Dec 2005 | $1.5M | Post-IPO | – | – | – |
2 investors in total: 2 institutional.
Investors in PharmaScience
PharmaScience has secured backing from 2 investors, including venture fund and institutional investors. Prominent investors backing the company include Dynex Capital and MMV Financial.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Tech & Life-Sciences focused Growth stage Venture Debt Firm investing in North America | mmvf.com | Toronto, Canada | ||
REIT that invests in residential and commercial mortgage loans | 1988 | dynexcapital.com | Glen Allen, United States |
Investor details for PharmaScience
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of PharmaScience
169 people are tracked at PharmaScience (50 in leadership, 1 in board & advisors, 118 in team).
| Name | Role | Group |
|---|---|---|
Mufaddal S. | Head- Generics Business Development | Leadership |
Paul Melekhov | Vice President | Leadership |
Sonia Girolamo | Vice President Finance, Information Technologies and Chief Financial Officer | Leadership |
Sylvie Brillon | Head, Supplier and CMO Quality Management | Leadership |
Valentina Ciuchi | Director R&d Analytical Services | Leadership |
Steve Martin | Global Head Marketing Commercial Operations & Business Development International Division | Leadership |
Yasser Hamza | Head Of Middle East And Africa Region | Leadership |
Eric Vincent | Senior Director, Global Generic Portfolio | Leadership |
Martin Lassonde | National Retail Sales Director | Leadership |
Ahmed Abdulatti | Director, Sales & Operation - GCC | Leadership |
David Goodman | CEO | Leadership |
Khanh Nguyen | Director, Business Development | Leadership |
Jean-François Laporte | Regional Business Director - Quebec | Leadership |
Glenn Lucsas | Senior VP Finance & CFO | Leadership |
Lynne Raymond | Regional Business Director | Leadership |
Graziana Salvatore | Human Resources Director | Leadership |
Paul Evans | VP - Global Business Development & Portfolio | Leadership |
Pierre Montanaro | VP General Manager Pharma Div | Leadership |
Corentin Gaillard | Commercial Director, US & Latam | Leadership |
Jean-Philippe Hamel | Directeur, Fiscalité / Tax Director | Leadership |
149 more people are available in the full profile.
Complete people profiles for PharmaScience
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Investments & Acquisitions by PharmaScience
PharmaScience has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Aegera Therapeutics.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Small molecule therapeutics for cancer and immune diseases are developed. | aegera.com | Montreal, Canada | 2000 | May 2011 | •••• |
Complete acquisition details for PharmaScience
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of PharmaScience
4 dated milestones of PharmaScience across 28 years, from founding to its latest funding, stage changes and deals.
- Founded PharmaScience is founded.
- Funding First funding round of $1.5M.
- Funding Latest funding round, Debt – Conventional, of $1.5M.
- Acquisition Acquires Aegera Therapeutics.
Web traffic of PharmaScience
The website of PharmaScience (pharmascience.com) receives about 13.8K visits a month and ranks #2,252,928 among all websites worldwide, #3,068 in Biotechnology and Pharmaceuticals.
- Monthly visits13.8K
▲ 24.4% vs previous month
- Unique visitors5.2K
per month
- Global rank#2,252,928
among all websites
- Category rank#3,068
Health · Biotechnology and Pharmaceuticals
- Bounce rate57%
- Pages per visit1.4
- Average visit13 sec
- DevicesDesktop 44% · Mobile 56%
Websites whose visitors overlap most with PharmaScience. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
taro.ca | taro.ca | 100% | #2,195,995 | – | |
| amgen.com | 92% | 495.4K | #116,434 | View details | |
tevacanada.com | tevacanada.com | 89% | #1,618,239 | – | |
| xenon-pharma.com | 80% | 19.4K | View details | ||
dtcperspectives.com | dtcperspectives.com | 75% | #4,862,537 | – | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 21 similar websites and full traffic analytics for PharmaScience
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 21 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Pharmascience
Complete news archive for PharmaScience
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about PharmaScience
PharmaScience was founded in 1983 and raised its 1st funding round 22 years after it was founded.
PharmaScience is headquartered in Montreal, Canada. It is registered at Montreal, Quebec, Canada.
PharmaScience was established in 1983 in Montreal, Canada, within the pharmaceutical sector. Generic, branded, and over-the-counter medications are produced across nearly 300 molecules in facilities compliant with regulatory standards. Domestic and international markets are served, while support resources and patient care programs are provided to healthcare professionals. A dedicated division handles specialty medications, and substantial resources are allocated to research and development efforts.
PharmaScience has made 1 acquisition, including Aegera Therapeutics.
PharmaScience has 2 investors. Key investors include Dynex Capital, and MMV Financial.
PharmaScience operates through Pharmascience Inc.